Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination With Anticancer Agents in Subjects With Selected Advanced Solid Tumors

NCT02723955 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02723955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02723955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination With Anticancer Agents in Subjects With Selected Advanced Solid Tumors
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
June 23, 2016
Completion date
July 5, 2023
Enrollment
829 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms